Join
Live feed
·
PRReleasevia Quantisnow
Assembly Biosciences Inc. logo
Gilead Sciences Inc. logo

Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASMB (Assembly Biosciences Inc.), GILD (Gilead Sciences Inc.) and more on Quantisnow.